Susan Hasty, Publisher
Table of Contents . . . May 27th, 1996Non-Subscriber - Summaries Only
Prevention - Trientine Protective Against Hepatitis/HCC
At-Risk Populations (IVDUs) - Hepatitis B and C Prevalent Among Injection Drug Users
Blood Banking (Pooled Plasma Derivatives) - IV Ig HCV Outbreak in US Was Not Properly Investigated
Blood Banking (Pooled Plasma Derivatives) - UK Investigators Follow-Up on Contaminated IV Ig Recipients
Blood Banking (Viral Inactivation) - Rutin Added to Fibrinogen Prevents Degradation during Irradiation
Case Study - Hepatitis Caused by BCG Treatment for Bladder Cancer
International (Europe) - French Firm Pays $42 Million for Vaccine Technology
Liver Fibrosis - Hyaluronan Superior as Marker of HCV Related Fibrosis
Obstetrics (HCV) - HCV Infection Does Not Increase Risk
Pathogenesis - Telomere Shortening Seen in HCC/Hepatitis Infection
Pathogenesis (HBV) - V-8 Protease-Digested HBV Can Infect HCC Cell Line
Therapy (HCV) - Low Dose Interferon Elicits 15 Percent Response Rate
Virology (HDV) - Ribozyme Critical in HDV Life Cycle
Pathogenesis (HCV) - "MHC Class II Antigens Expression and Dendritic Cells in PBC and Chronic Hepatitis C." Z. Krastev, L. Mateva, R. Ivanova, A. Alexiev and B. Alexiev. Clinic of Gastroenterology, University
Diagnostics (HCV) - "Comparative Evaluation of Two Serologic Typing Methods for Hepatitis C Virus."
Transplantation (Liver) - "Recurrent Hepatitis C Virus Hepatitis in Liver Transplant Recipients Receiving Tacrolimus: Association with Rejection and Increased Immunosuppression after Transplantation."
Transplantation (Renal) - "A Prospective Study of Hepatitis C Virus Infection in Renal Allograft Recipients."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.